Dolby Laboratories (DLB) Financials
DLB Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 2.9 billion | 573.2 million |
2023-09-30 | 3.0 billion | 607.6 million |
2023-06-30 | 3.0 billion | 625.2 million |
2023-03-31 | 2.8 billion | 480.1 million |
DLB Free Cash Flow and Stock based compensation
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | 2.3 million | 31.9 million |
2023-09-30 | 76.8 million | 28.2 million |
2023-06-30 | 113.7 million | 29.2 million |
2023-03-31 | 97.0 million | 29.8 million |
DLB Net Income
Date | Net Income |
---|---|
2023-12-31 | 67.0 million |
2023-09-30 | 9.9 million |
2023-06-30 | 16.4 million |
2023-03-31 | 95.9 million |
DLB Cash and Debt
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | - | - | 47.2 million |
2023-09-30 | 884.5 million | - | 50.6 million |
2023-06-30 | 889.3 million | - | 50.1 million |
2023-03-31 | 814.8 million | - | 47.9 million |
DLB Shares Outstanding
DLB Expenses
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 6.1 million | 67.0 million | 144.2 million | - |
2023-09-30 | 8.2 million | 70.4 million | 66.6 million | 90.9 million |
2023-06-30 | 7.4 million | 68.7 million | 70.0 million | 85.6 million |
2023-03-31 | 7.5 million | 68.0 million | 61.9 million | 95.7 million |
DLB Cost of Revenue
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 315.6 million | 32.1 million |
2023-09-30 | 290.6 million | 35.6 million |
2023-06-30 | 298.4 million | 41.5 million |
2023-03-31 | 375.9 million | 41.0 million |
DLB
List: Contenders
Price: $79.58
Dividend Yield: 0.01%
Forward Dividend Yield: 1.51%
Payout Ratio: 62.50%
Dividend Per Share: 1.20 USD
Earnings Per Share: 1.92 USD
P/E Ratio: 41.36
Exchange: NYQ
Sector: Industrials
Industry: Specialty Business Services
Volume: 759000
Ebitda: 104.8 millionMarket Capitalization: 7.7 billion
Average Dividend Frequency: 4
Years Paying Dividends: 11
DGR3: 8.26%
DGR5: 11.72%